ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Battling Patent Laws: The Glivec Case

Novartis has lost its case challenging the constitutional validity of Section 3(d) of the Indian Patents Act 1970, but the celebratory air needs to be tempered. The issue of what constitutes enhanced efficacy of a drug is not in general settled. But, more importantly, from the perspective of making the right to heathcare a reality, there is a strong case for certain therapeutic classes of drugs important for public health being taken outside the purview of legal disputation.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top